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Introduction {#sec1}
============

Recent years have seen the emergence of many new cell culture approaches to improve the relevance of *in vitro* experiments to the behavior of the cells residing within living tissues. One of the main objectives of these methods is to recapitulate the native cells' microenvironment, including biochemical signaling delivered from the blood stream or from neighboring cells, formation of intercellular junctions, interactions with the endogenous extra-cellular matrix (ECM), mechano-transduction, and effects such as diffusion gradients ([@bib38]). The three-dimensional (3D) culture formats that have emerged range from culturing individual cells in hydrogel matrices ([@bib43]) or de-cellularized scaffolds ([@bib46]), to making functional aggregates such as spheroids ([@bib7]) or organoids ([@bib34]), to building more complex engineered structures that involve multiple cell types on a microfluidic device ([@bib9]). The combination of microfluidics and 3D cell culture has allowed the emergence of a range of organ-on-a-chip approaches that include many of these strategies ([@bib70]).

These formats are not meant to replace two-dimensional (2D) culture. Instead, they will allow specific questions to be asked on more physiologically relevant culture models. Some of these questions can only be asked in specific 3D formats, such as questions related to embryogenesis ([@bib60]), tumor-stromal interactions ([@bib20]), or the effect of vascularization on tumor growth ([@bib11]). In contrast, other applications depend on cellular phenotypes that are modified when the cells are cultured in 2D versus 3D, such as the function of hepatocytes ([@bib17]), chondrocytes ([@bib50]), pancreatic cells ([@bib35]), neural cells ([@bib12]), or lung cells ([@bib31]) and the impact of this function on their response to toxic compounds ([@bib27]). Therefore, the most suitable technological format for a particular question will balance the level of biological complexity that is required with the desired throughput and the necessary ease of use and reproducibility of the experiment.

In this context, spheroids present an appealing format for 3D culture, because they combine a moderately high level of biological complexity with simple production protocols ([@bib16]). The biological function is enhanced in spheroids compared with 2D cultures ([@bib7], [@bib41], [@bib8], [@bib63]), while cells have been shown to produce their own ECM and interact with it ([@bib66]). However, despite the long history of spheroid cultures ([@bib54]) and the ability to produce them in large quantities in bulk formats ([@bib58]), the manipulation and observation of individual spheroids remains largely manual and labor intensive.

Two main approaches are used to form, culture, modulate, and image spheroids: multiwell plate-based systems and microfluidic devices. Methods based on modifications of multiwell plates ([@bib57], [@bib61], [@bib24]) enable reliable formation of a single spheroid per well but suffer from high volumes when using expensive reagents, like Matrigel or antibodies, and do not comply with perfusion protocols. Low-adhesion microwells in microfluidic chambers ([@bib33], [@bib37]) overcome these disadvantages but lose the compartmentalization of each spheroid, which prevents multiplexing and hydrogel encapsulation. Microfluidic encapsulation in liquid droplets ([@bib3], [@bib10], [@bib51]) simplifies the use of hydrogels, but the lack of droplet control limits the implementation of sequential protocols, as well as the actual throughput of quantification because of the difficulty of imaging free droplets over time.

To address these limitations, we have demonstrated a data-driven approach to spheroid culture. This approach is based on a microfluidic platform that integrates many necessary operations for the regulation of spheroid behavior *in vitro* while providing several hundred independent cultures per experiment on a single microscope-slide format ([@bib47]). The approach is uses so-called anchored droplets ([@bib1]) in which spheroids are formed, manipulated, and observed over several days in culture. The ability to perform precise image analysis on the single-cell level, while combining results on thousands of spheroids, enables the mapping of cellular function depending on position within the spheroids, thus providing a link between the spheroid structure and the biological function of the cells within it. However, the platform could not address spheroids individually with a specific condition, nor did it allow a succession of operations to be performed on them.

In the present paper, we build on our previous results to allow random and time-dependent operations on each spheroid. This is achieved by introducing a new asymmetric design for the anchors, which leads to a qualitative transformation in the functionality of the microfluidic approach for a range of applications. The physical principles of the devices and the protocols that allow combinatorial operations are first explained, followed by the description of two key classes of applications. First, we describe the ability to bring cells into contact for building complex tissues, studying the self-organization of stem cells, investigating antagonistic interactions between cell types, or incorporating a hydrogel like Matrigel into the droplets. These results have immediate applications in several areas of biological research, such as tissue engineering, models of immuno-therapies, or understanding host-pathogen interactions. Then, we describe how the platform can be used to investigate different conditions and to obtain a detailed drug dose-response on hepatocyte-like spheroids. The behavior is tracked by combining measurements of the time evolution of hundreds of spheroids with a single-cell resolution. The dynamic that emerges is fundamentally linked with the 3D structure of the spheroids and shows a strong effect of cell-cell interactions on their response to the drug.

Results {#sec2}
=======

Physical Principles of Differential Anchoring {#sec2.1}
---------------------------------------------

To understand the principles underlying the device operation and robustness, we recall that confined droplets (e.g., water-in-oil droplets) are subjected to a trapping force in regions where they reduce their surface area and thus their surface energy ([@bib1], [@bib13]). Therefore, by designing microfluidic devices in which the droplets are confined everywhere except in localized regions, as sketched in [Figure 1](#fig1){ref-type="fig"}A, one can define positions at which the droplets can be anchored. The efficiency of this immobilization depends on the relative strength of the anchoring force, which is given by the gradient of surface energy, and by the drag force resulting from the flow of the outer fluid: as long as the anchoring force is stronger than the drag force, the droplet will remain immobile even if the outer fluid is flowing ([@bib13], [@bib68]).Figure 1Physical Principles of Differential Anchor Strengths(A) Side view and top view of a confined aqueous droplet near a capillary anchor. The brown arrows represent the direction of the external oil flow.(B) Two anchoring strengths can be distinguished: for narrow anchors (blue regions), the droplet only partially enters the anchor, whereas for wide anchors (red regions), the droplet entirely enters the anchors. This leads to an anchoring efficiency that depends on droplet size for the narrow anchors and to nearly irreversible trapping in the wide anchors.(C) Side view and top view of an asymmetric anchor. The wide (d~1~ \> 2h) and narrow (d~2~ \< 2h) regions can be combined into a single capillary anchor by designing asymmetric shapes. Thick dashed lines denote the planes of the corresponding side views.

When the droplet is above the anchor, the curvature of the interface will tend to homogenize to equilibrate the Laplace pressure jump between inside and outside. Therefore, geometric considerations define two limits that lead to two regimes ([Figure 1](#fig1){ref-type="fig"}B). First, in the case of wide anchors, i.e., when the anchor diameter d is larger than around 2h, the equilibrium position for the droplet is penetration of the anchor as long as the hole is sufficiently deep ([@bib13]). This leads to high trapping efficiency as a large reduction of the surface area is combined with a weak drag force, because the droplet exposes only a small region in the channel where the fluid is flowing. Conversely when $d \lesssim 2h$, the equilibrium position corresponds to the droplet only partially entering the anchor. In this situation, the droplet is trapped by the anchor only if the outer fluid is flowing below a critical velocity that depends on the physical parameters (viscosity and surface tension) and on the droplet size. A detailed analysis shows that this critical velocity rapidly decreases as the droplet size increases ([@bib13]) (see [STAR Methods](#sec4){ref-type="sec"} for detailed discussion).

These principles can guide the design of anchors that have regions with different trapping efficiencies, as shown, for example, in [Figure 1](#fig1){ref-type="fig"}C. The red-shaded region of this anchor displays a large diameter d~1~ and thus can accommodate a large droplet and trap it with a high efficiency while keeping the blue region free to receive a second droplet. In contrast, the characteristic dimension d~2~ of this second region is smaller than 2h, so a second droplet will only be able to partially enter the blue region and therefore will be trapped with a weaker force. Depending on the design details of this shape, the contrast between the two trapping efficiencies can be very large, leading to nearly irreversible trapping in the red regions and much weaker trapping in the blue regions.

Protocol for Droplet Pairing and Fusion {#sec2.2}
---------------------------------------

This differential trapping system can be exploited to generate pairs of droplet with different contents. This is achieved in a microfluidic chip whose main feature is a large trapping chamber with an array of asymmetric anchors ([Figure 2](#fig2){ref-type="fig"}A). The protocol generally begins by bringing into the oil-filled chamber a population of large aqueous droplets and allowing them to randomly occupy the strong regions of the anchors, as shown in [Figure 2](#fig2){ref-type="fig"}B (left). Once all anchors are filled, a second population of smaller droplets is transported into the trapping region, where they are trapped in the triangular parts of the anchors (right). Beyond simply trapping the smaller droplets, the triangular shape of the anchors produces a local gradient of confinement that pushes the two droplets in each anchor into intimate contact ([@bib18]). As such, flushing an emulsion destabilization agent in the outer phase results in the quick merging of the two types of droplets ([Figure 2](#fig2){ref-type="fig"}C; [Video S1](#mmc2){ref-type="supplementary-material"}). Because the excess droplets that are not trapped can be flushed away before triggering coalescence, one merging event reliably takes place in each anchor.Figure 2Microfluidic Protocols for Pairing and Merging Different Droplet Populations (Aqueous Droplets in Oil)(A) Design of the microfluidic chips.(B--E) Images show portions of the trapping area. (B) First, a population of large droplets is injected and allowed to fill the large regions of each anchor, followed by a second population of smaller droplets. The small droplets (dark dye) then occupy the triangular regions of each anchor. Scale bar is 200 μm. (C) Flushing the device with an emulsion destabilization agent (PFO, perfluoro-octanol; [@bib56], [@bib2]) results in the merging of the touching droplets, which allows their contents to mix in a few seconds. Scale bar is 100 μm. (D and E) Droplet libraries can be produced in a different microfluidic device and re-injected into the trapping region. In the current example, the large droplet population contains variable concentrations of dye ranging from blue, to green, to yellow. The small droplets contain a gradient of red dye. Image of 80 anchors filled with 2 sets of colored droplets before (D) and after (E) merging. Scale bar is 1 mm.(F and G) Quantification of the droplet colors in red, green, and blue (RGB) space before (F) and after (G) the coalescence (dot color corresponds to RGB coordinates; n~chips~ = 1, n~droplets~ = 351).All corresponding flows can be found in [Table S1](#mmc1){ref-type="supplementary-material"}.

Video S1. Coalescence of the Droplet Array upon PFO Perfusion, Related to Figure 2After coalescence, the droplet color fading indicates the reaction of the dark dye (2,6-DCPIP) with the oxygen carried by the oil. Time is shown in min:sec.

Alternatively, one or both populations can be produced in a different device ([@bib19], [@bib30]), stored off-chip, before being re-injected into the trapping region. In this way, droplet libraries can be generated independently and later brought into contact with a sample of interest that is immobilized in the capillary anchors. Such a protocol is demonstrated in [Figures 2](#fig2){ref-type="fig"}D and 2E, where two droplet populations, containing food dye as a proxy for chemical content, are merged. In this example, each of the libraries was produced on a separate chip through a confinement gradient ([@bib14]), as described in [Figure S1](#mmc1){ref-type="supplementary-material"}. The large droplets were formed by mixing yellow and blue solutions, while the small droplets contained a gradient of red dye. The large and small droplets were then sequentially loaded into the anchors to yield more than 350 merged droplets each containing a unique color ([Figures 2](#fig2){ref-type="fig"}F and 2G).

The demonstrations of [Figure 2](#fig2){ref-type="fig"} show the ability to bring together two droplets in each microfluidic anchor. Next, we show how this technology can be applied to cell manipulation, thus enabling unique operations on 3D cultures toward tissue engineering or applications requiring different conditions on a single device.

Cellular Interactions and Hydrogels in Anchored Droplets {#sec2.3}
--------------------------------------------------------

When a suspension of cells is encapsulated in the droplets, the cells aggregate to form a single functional sphere of adherent cells in each anchored droplet ([@bib47]). This protocol can be implemented in the current asymmetric anchors ([Figure 3](#fig3){ref-type="fig"}A) to produce a spheroid in the large droplet of each anchor. The second droplet can then be used to bring some fresh medium or a different cell population that can interact with the original spheroid in various ways, as illustrated in [Figure 3](#fig3){ref-type="fig"}. A few examples of synergistic or antagonistic interactions are described later.Figure 3Regulation of the Biological Environment in Droplets(A) Design of the asymmetric anchors adapted for the droplet spheroid formation and culture (side view corresponds to the thick dashed line in the top view).(B and C) Protocol for spheroid merging scheme (B) and corresponding micrographs showing 2 consecutive merging events with H4-II-EC3 spheroids (C, scale bar is 50 μm).(D) Micrographs of 2 heterospheroids with different configurations after the protocol shown in (C). Scale bar is 20 μm.(E--G) Selected micrographs showing co-culture experiments with: hMSCs CD146^bright^ (magenta) and hMSCs CD146^dim^ (green), which were sorted by flow cytometry (E, scale bar is 20 μm); Jurkat cells and A673 spheroids (F, scale bar is 20 μm); H4-II-EC3 spheroids and *E. coli* (G, scale bar is 50 μm).(H) Matrigel addition through the second droplet after spheroid formation.(I) B16-F0 cells (mouse melanoma) were imaged just after Matrigel addition (D+2) and the next day (D+3). Black arrows highlight some cell protrusions through the hydrogel matrix. Scale bar is 20 μm.Additional quantification is provided in [Figure S2](#mmc1){ref-type="supplementary-material"}.

First, complex tissues can be constructed by successively, bringing into contact different cell populations. In the first example ([Figures 3](#fig3){ref-type="fig"}B and 3C), a single H4-II-EC3 cell spheroid (a rat hepatoma cell line) was formed in each droplet trapped in the strong region of an anchor. The operation was repeated with a smaller droplet in the triangular region to form a single magenta-stained spheroid. After droplet pair merging, the two spheroids of each anchor came into contact in the resulting merged droplet and initiated fusion to form a composite spheroid (D+3). Because the volume of the small droplet was much smaller than that of the large droplet, the triangular region of the anchor was left empty after this first droplet merging. In this way, another trapping/merging cycle was possible, for instance, with a new set of droplets containing cells stained green. This sequential three-step process resulted in the formation of a single composite microtissue in each anchor of the microfluidic chamber. The resulting microtissues had various shapes ([Figure 3](#fig3){ref-type="fig"}D), though a statistical analysis showed that the green spheroids were more likely to merge with the first two along their elongated side, resulting in a dominance of triangular structures ([Figures S2](#mmc1){ref-type="supplementary-material"}A--S2C).

The ability to merge two spheroids can be used to address the self-organization of stem/progenitor cells in 3D by working with a primary population of human mesenchymal stem cells. As with most progenitor cell populations, these cells presented a varying degree of commitment toward differentiated states ([@bib25], [@bib52], [@bib32]). It is not known how this heterogeneity is reflected in the structural organization of the spheroid.

To address this question, the cells were sorted, using flow cytometry, based on their level of expression of a characteristic marker for the differentiation (CD146) ([@bib45]). This sorting resulted in the isolation of low (CD146^dim^) and high (CD146^bright^) fluorescent cells, which were then used to form spheroids in the large and the small droplets, respectively. After droplet merging, the two spheroids fused and the cells self-reorganized into a core-shell structure, with the CD146^bright^ cells in the core and the CD146^dim^ cells forming the shell ([Figure 3](#fig3){ref-type="fig"}E). The transition from side-by-side spheroids to the core-shell structure was found to reproducibly take place within a 24 h period ([Figures S2](#mmc1){ref-type="supplementary-material"}D and S2E).

The structural organization that emerged from these spheroid fusions was identical to the self-arrangement obtained when the different cell populations were seeded together in the same droplet ([@bib48]). However, those experiments could not distinguish between kinetic effects, related to the speed of aggregation of the different cell types, and the biophysical effects, related to the affinity of different cells. By avoiding the kinetic effects, the experiments shown here confirmed that human mesenchymal stromal cells (hMSCs) self-organized in a hierarchical manner in 3D because of cell-cell affinities.

In addition to these synergistic interactions, the droplet merging can be used to explore host-pathogen or other antagonistic interactions between cell types. For instance, the microfluidic approach is well suited for studying the interaction of immune-like cells with a cancer spheroid *in vitro*. A simple example of such an interaction is obtained by bringing into contact a spheroid of A-673 cells (Ewing's sarcoma) with a suspension of individualized Jurkat cells ([Figure 3](#fig3){ref-type="fig"}F). These immune cells form robust junctions with the cancer spheroid and begin to interact with the cancerous cells in each of the anchors.

Another example is shown in [Figure 3](#fig3){ref-type="fig"}G, where a well-formed spheroid (H4-II-EC3 cells) is brought into contact with a droplet containing a dilute suspension of *E. coli* (MG-1655-GFP, green; [Figure 3](#fig3){ref-type="fig"}G). After one day in culture. *E. coli* colonized the whole volume of the droplets concomitantly with a significant decline of H4-II-EC3 viability ([Figures S2](#mmc1){ref-type="supplementary-material"}F--S2I).

Beyond cell-cell interactions, the second droplet can modify the physical properties of the spheroid microenvironment, for example, by introducing a hydrogel into the droplet. The hydrogel can then be solidified to initiate interactions with the cells, as shown in [Figure 3](#fig3){ref-type="fig"}H. Here, B16-F0 cells (mouse melanoma) showed clear protrusions through the matrix ([Figure 3](#fig3){ref-type="fig"}I), oriented in different directions ([Figures S2](#mmc1){ref-type="supplementary-material"}J--S2L), one day after hydrogel incorporation. Finally, combinations of an inert gel (e.g., agarose) with cells in the second droplet can also be used as a porous barrier that allows paracrine signaling without allowing the cells to migrate through them, which functions as a Transwell in a droplet ([Figure S3](#mmc1){ref-type="supplementary-material"}).

The preceding examples are meant to illustrate the range of interactions that are possible in the device. Learning new biology from these protocols will require more detailed experiments and analysis, including the choice of the most relevant cell types. Nevertheless, the examples of [Figure 3](#fig3){ref-type="fig"} confirm that the microfluidic droplet format is compatible with a range of cell types in various situations and that it can be used to observe their interactions.

Dynamic Measurement of Drug Toxicity on Spheroids {#sec2.4}
-------------------------------------------------

Beyond looking at cellular interactions and hydrogels, the microfluidic platform lends itself to investigating the influence of different chemical conditions in each droplet. As a demonstration of the type of approaches that can be applied, we show how the asymmetric anchors can be used to test several culture environments on H4-II-EC3 cell spheroids ([Figure 4](#fig4){ref-type="fig"}A). Spheroids are first formed in the large droplets and allowed to incubate overnight. In parallel, a library of secondary droplets is produced in a different device, following protocols similar to those described in [Figure 2](#fig2){ref-type="fig"}. The secondary droplets are then injected into the microfluidic chamber and paired with the spheroid-containing drops ([Figure 4](#fig4){ref-type="fig"}B). To recognize the individual conditions in each drop, different fluorescent barcodes ([@bib15]) are prepared by combining 3 concentrations of 3 fluorescent dyes (CF™350, CF™488A, and CF™647; see [STAR Methods](#sec4){ref-type="sec"}).Figure 4Multiplexed Conditions on Liver Spheroids(A and B) Timeline (A) and schematic top view of an anchor (B) showing the experimental protocol.(C--E) Chemical droplet library. Droplets with 27 color barcodes were randomly trapped in capillary anchors and merged with H4-II-EC3 spheroid droplets (C, montage of 224 droplets, n~chips~ = 2, scale bar is 1 mm). (D) Distribution of the 27 barcodes in all droplets. Each bar corresponds to one barcode, with matching colors. APAP was only added in the droplets with barcode 9. (E) Micrograph of 2 droplets 24 h after library merging. Barcode 9 corresponds to the APAP droplet. PI fluorescent intensity is shown in red. Scale bar is 100 μm.(F) Polydispersity histogram of the spheroids produced in this study (n~chips~ = 4, n~spheroids~ = 685). CV = standard deviation/mean.(G) Calibration of the fluorescent signal of the CF™488A dye (green, n~droplets~ = 429) and CF™647 dye (magenta, n~droplets~ = 455) for the drug concentration determination. The detailed protocol is explained in [STAR Methods](#sec4){ref-type="sec"}. The black circles and error bars represent the mean over all droplets of each concentration and the standard deviation, respectively. The colored lines represent a linear fit of the data.(H and I) Montages of 6 micrographs showing anchors with single liver spheroids (H4-II-EC3 cells) before (H, scale bar is 200 μm) and after (I) drug droplet trapping. The green and magenta fluorescent dyes correspond to the APAP stock solutions at low and high concentrations, respectively, used for creating the droplet library.(J) Micrograph of the entire chip array after droplet coalescence (n~spheroids~ = 252, montage of the cropped anchors). The white rectangle represents the location of the droplets displayed in (C) and (D). Scale bar is 1 mm.

After droplet trapping and merging, the 27 conditions were randomly distributed in the array ([Figure 4](#fig4){ref-type="fig"}C) and each condition could be identified from the color of the fluorescent signal ([Figure S4](#mmc1){ref-type="supplementary-material"}). Given the number of conditions and anchors, each barcode was represented between 1 and 15 times ([Figure 4](#fig4){ref-type="fig"}D; see [STAR Methods](#sec4){ref-type="sec"} for statistical design of the library). At the production stage of the droplets' fluorescent barcodes, acetaminophen (APAP, a drug known for its hepatotoxicity; [@bib59]) was added in a single barcode solution, resulting in the specific killing of the corresponding spheroids 1 day after exposition ([Figure 4](#fig4){ref-type="fig"}E).

In this proof-of-concept experiment, APAP was identified as hepatotoxic; therefore, we investigated the concentration-dependent APAP toxicity on H4-II-EC3 cell spheroids. We first verified that the spheroid size was well controlled by measuring the coefficient of variation (CV) of the diameter, which was around 10% for this cell type ([Figure 4](#fig4){ref-type="fig"}F). Then, we subjected the spheroids to a large gradient of APAP concentrations, which was prepared as described in [STAR Methods](#sec4){ref-type="sec"}. The APAP stock solution was marked with a magenta fluorescent probe, while the dilutant solution contained a green fluorescent probe. In this way, the two fluorescent signals could be used to determine the APAP concentration in each of the droplets ([Figure 4](#fig4){ref-type="fig"}G). These drug droplets were injected into the chip, trapped, and merged with the spheroid droplets ([Figures 4](#fig4){ref-type="fig"}H and 4I). Consequently, the spheroids on a single device were exposed to a range of APAP concentrations covering three decades ([Figure 4](#fig4){ref-type="fig"}J), and the evolution of cell death was dynamically monitored for 36 h in each spheroid by live viability staining. Diffusion of the mortality dye (propidium iodide \[PI\]) was verified to occur within a few tens of minutes ([Figure S4](#mmc1){ref-type="supplementary-material"}).

The results at the low and high extremes of the concentration range were as expected: spheroids that were exposed to control droplets or low APAP concentrations remained viable for the duration of the experiment ([Figure 5](#fig5){ref-type="fig"}A), whereas the viability of the spheroids exposed to high APAP concentrations was altered ([Figure 5](#fig5){ref-type="fig"}B). The mean viability at 24 h displayed the typical sigmoidal shape on a logarithmic scale ([Figure 5](#fig5){ref-type="fig"}C), with a half maximal inhibitory concentration (IC~50~) of 18.0 mM (a similar value is found in 2D; [Figure S5](#mmc1){ref-type="supplementary-material"}). The variability among microfluidic chips was very low, because the IC~50~ CV was only 3% (n~chips~ = 4). The IC~50~ value of 18.0 mM was close to the value reported in the literature ([@bib17], [@bib42]), for similar cells like HepG2 ([@bib49]). Because cytochrome (CYP) enzymes play a major role in APAP toxicity ([@bib28]), liver cells that express higher levels of CYP enzymes, like HepaRG cells ([@bib4]), are more sensitive to APAP, with an IC~50~ close to 5 mM ([@bib22], [@bib67]).Figure 5Measurment of APAP Toxicity on H4-II-EC3 Spheroids(A and B) Time-lapse images showing a spheroid without drug (A, after merging with a control droplet) and a spheroid exposed to a 48.7 mM APAP concentration (B), in bright field (bottom) and with fluorescent viability staining (top).(C) Viability values at the spheroid level after a 24 h exposure (n~spheroids~ = 685). Each black dot represents one spheroid, and the red and blue curves represent the mean behavior and a sigmoidal fit of the data, respectively, with the blue dashed lines highlighting the IC~50~ value of 18.0 mM.(D) Time-lapse images showing a spheroid exposed to a 22.1 mM APAP concentration with PI (red). White dots are the locations of the detected dead nuclei, and the cross represents the spheroid center. R is the equivalent radius of the spheroid, and r is the distance to the spheroid center.(E and F) Time evolution of the number of dead cells detected on one spheroid image (E) and of the mean normalized distance $\left( {r/R} \right)_{dead}$ of the dead cells to the spheroid center (F) depending on the drug concentration. Scale bars are 50 μm.

More interestingly, the experiments yielded a deeper understanding of the drug response when the time evolution of each spheroid was tracked at the level of individual cells ([Figure 5](#fig5){ref-type="fig"}D). For this purpose, we detected the apparition of dead cells as a function of time ([Figure 5](#fig5){ref-type="fig"}E) and measured their distance to the spheroid center $\left( \left( {r/R} \right)_{dead} \right)$ for each of the 685 spheroids ([Figure 5](#fig5){ref-type="fig"}F; see [STAR Methods](#sec4){ref-type="sec"} for the image analysis details, with individual curves shown in [Figure S6](#mmc1){ref-type="supplementary-material"}). At low APAP concentrations, the number of dead cells remained below five cells per image and their mean location in the spheroid was constant and close to the spheroid edge ($\left( {r/R} \right)_{dead}\  \approx \ 0.75$, light and dark blue lines). For higher APAP concentrations, the number of dead cells increased significantly after 10 h to reach up to 30 dead cells at the end of the experiment, corresponding to all cells on an epifluorescence image. In addition, the position of these dead cells shifted toward the spheroid center with time and concentration, with $\left( {r/R} \right)_{dead}$ dropping from 0.68 to 0.55 for an APAP concentration higher than 40 mM (red line). This indicated that the drug concentration influenced the number and the location of dead cells within the spheroids in a time-dependent manner.

The single-cell level of detail allowed us to address the wide spread that was observed for intermediate concentrations of APAP. For APAP concentrations between 15 and 23 mM, spheroids could have a very low, very high, or intermediate viability ([Figure 6](#fig6){ref-type="fig"}A). One major parameter for explaining this spread was the presence of dead cells in the spheroids at the outset of the experiment. Spheroids with at least one dead cell at t = 0 h displayed, at t = 24 h, a significantly lower viability (24%) than the spheroids without dead cells initially (60%, [Figure 6](#fig6){ref-type="fig"}B). Moreover, the location of these first detected dead cells was significantly correlated to the viability after 24 h ([Figure 6](#fig6){ref-type="fig"}C): the spheroid was more likely to have a low viability at t = 24 h when the first dead cell was close to the spheroid center ($\left( {r/R} \right)_{dead}$ \< 0.7). The signature of the initial state was again visible when observing the time evolution of the viability of each spheroid ([Figure 6](#fig6){ref-type="fig"}D; [Figure S6](#mmc1){ref-type="supplementary-material"}), in which the curves displayed different trends depending on the presence or absence of a dead cell initially. This observation motivated us to question what part of the viability dynamics was determined by the drug concentration and what part depended on the eigenstate (the structure, interactions, and initial spheroid state) of each spheroid in time. To evaluate the effects, we defined two timescales to describe the evolution of each spheroid, as sketched in [Figure 6](#fig6){ref-type="fig"}E: the time to reach 75% viability $\left( \text{τ}_{75} \right)$ and the time required to drop from 75% to 25% viability $\left( {\Delta\text{τ}_{75 - 25}} \right)$. The first timescale could be considered the time required for the cells to begin responding to the drug, while the second one described the time required to kill the spheroid once the process began. These two parameters were found to be independent of each other ([Figure 6](#fig6){ref-type="fig"}F). They also had different mean values and variances ([Figure 6](#fig6){ref-type="fig"}G), such that $\Delta\text{τ}_{75 - 25}$ could be considered nearly constant compared with $\text{τ}_{75}$. Indeed, $\tau_{75}$ showed a significant dependence on APAP concentration, dropping from 18 to 8 h for APAP concentration from 10 to 70 mM ([Figure 6](#fig6){ref-type="fig"}H), while $\Delta\text{τ}_{75 - 25}$ remained constant close to 7 h for all concentrations ([Figure 6](#fig6){ref-type="fig"}I). These measurements suggested that $\text{τ}_{75}$ was the more relevant parameter to understand the effect of the drug, while $\Delta\text{τ}_{75 - 25}$ was characteristic of the response of these spheroids to a change in their microenvironment.Figure 6Analysis of the Viability(A) Toxicity values after a 24 h exposure. Data points corresponding to spheroids exposed to a 14--23 mM range of APAP concentrations are highlighted in purple (same dataset as [Figure 5](#fig5){ref-type="fig"}C).(B) Influence of the number of initial dead cells on the viability after a 24 h exposure for an APAP concentration between 15 and 23 mM (red, at least one initial dead cell; blue, no initial dead cell; n~spheroids~ = 98).(C) Correlation between the viability at t = 24 h and the mean normalized distance of the first detected dead cells (whatever its time of appearance) to the spheroid center $\left( {r/R} \right)_{first\ dead\ cells}$ (n~spheroids~ = 308), for an APAP concentration between 10 and 40 mM.(D) Dynamic evolution of the spheroid viability for an APAP concentration between 15 and 23 mM. Each thin line represents one spheroid (n~spheroids~ = 98); the red and blue curves correspond to the spheroids that had at least one detected dead cell and no detected dead cell at t = 0 h, respectively; and the thick black line represents the overall mean.(E) Definition of the time needed to reach a 75% viability $\tau_{75}$ and the time to go from a 75% to a 25% viability ($\Delta\tau_{75 - 25}$ = $\tau_{25}$ − $\tau_{75}$) on a viability followup corresponding to a spheroid exposed to a high APAP concentration (above 40 mM).(F) Low correlation (Pearson's correlation coefficient = −0.06) between $\Delta\tau_{75 - 25}$ and $\tau_{75}$ (n~spheroids~ = 215) shows that the two parameters are independent.(G) Evaluation of $\tau_{75}$ (n~spheroids~ = 262) and $\Delta\tau_{75 - 25}$ (n~spheroids~ = 215).(H and I) Evolution of $\tau_{75}$ (H) and $\Delta\tau_{75 - 25}$ (I) with the APAP concentration.N.S., nonsignificant; ^∗^p \< 0.05, ^∗∗^p \< 0.01, ^∗∗∗^p \< 0.001. Statistical test details are provided in [Table S2](#mmc1){ref-type="supplementary-material"}.

Discussion {#sec3}
==========

As the demand for highly relevant culture models becomes stronger ([@bib23]), many approaches have been explored for structuring 3D cultures that capture essential aspects of the *in vivo* microenvironment ([@bib40]). Among these approaches, spheroids constitute an interesting format that balances biological relevance while remaining simple to produce in large quantities. Nevertheless, spheroid manipulation remains laborious and technical, which severely limits the ability to generate large datasets on various culture conditions ([@bib16]). In this context, we have recently demonstrated the ability to obtain multiscale cytometry by performing phenotypic measurements (*in situ* immuno-cyto-chemistry, qRT-PCR on recovered spheroids, and ELISA on the chip supernatant) on 10^5^--10^6^ individual cells *in situ* within thousands of spheroids ([@bib47]). We showed elsewhere that similar microfluidic techniques can be applied to the study of single CHO-S (Chinese ovary) cells ([@bib62]). Here we complete the toolbox by developing a protocol to manipulate independently the hundreds of spheroids present on a microfluidic device in a time-dependent manner.

The ability to generate the cellular interactions and data on large numbers of spheroids requires protocols that combine many individual operations, as shown earlier. Although most of these operations are available individually on alternative platforms or with other 3D culture formats ([@bib69]), integrating them into a complete protocol requires a high level of robustness and tolerance to errors, because each new step can introduce new sources of error. The current platform is expected to display particularly strong performance for a range of applications, such as for generating large amounts of single-cell data on a few well-controlled conditions. This improvement in performance stems from the use of microfluidics to handle the fluids, the encapsulation offered by the droplet methods, the tolerance of stationary droplet methods to experimental error, and the integration of all operations on a single device.

The protocols shown here are based on the ability to reliably pair two droplets at any moment over a period of several days. For this, the current microfluidic design uses anchors composed of regions with two widely varying trapping strengths, such that the primary droplet can be trapped nearly irreversibly while other droplets are brought into contact at later times. This contrast in trapping efficiencies makes the device operation possible for a range of physical and experimental parameters (viscosities, flow rates, droplet sizes, etc.), which translates into stronger robustness and stability compared with existing designs (e.g., [@bib6], [@bib26], [@bib18], [@bib56]). These qualities bring droplet microfluidics closer to the functionalities of multiwell plates in which any multistep chemical or biological assay is possible ([@bib29]).

If the first droplet contains a spheroid, the second droplet can be used to bring fresh culture medium to increase the culturing time in confined droplets. More interestingly, the user can add different cell types, for example, to build microtissues within the droplets ([@bib10]), to study cell-cell interactions ([@bib39]), or to reproduce crucial steps in development ([@bib5]). Applying our microfluidic approach to these problems leads to the emergence of non-trivial cellular organizations within the fused spheroids: when the cell types constituting each spheroid are homogeneous, the fusion of two spheroids display a side-by-side juxtaposition (e.g., [Figure 3](#fig3){ref-type="fig"}D). In contrast, when the cell types have different phenotypes, a core-shell structure is observed (e.g., [Figure 3](#fig3){ref-type="fig"}E). The microfluidic format is unique in its ability to easily scale up these fusions to hundreds of parallel microtissues per experiment.

Alternatively, the format allows the study of antagonistic interactions as in immuno-therapy models ([@bib21]) or host-pathogen interactions ([@bib64]), with potential applications to drug development or basic biology. Furthermore, the second droplet can contain a hydrogel that is gelled after the droplet fusion, which can also be used for a range of applications, such as for metastasis invasion assays ([@bib20]) or as functionalized scaffolds to capture secreted molecules ([@bib43]).

Beyond these illustrative examples, the ability to manipulate individual spheroids allows us to test the toxicity of a drug on 3D cultures. For this, we adapt previous work that uses fluorescent droplet barcoding ([@bib71], [@bib72], [@bib73]) to identify APAP droplets inside a pool of 26 other colors and confirm its toxicity on liver spheroids. Although such multiplexing is not yet sufficient for high-throughput screening, the amount of detail that can be obtained by the image analysis allows us to address fundamental questions on 3D cell culture.

To this end, we perform a complete analysis of the toxicity of APAP over a range of three decades in concentration. This analysis includes generating the droplet library, merging the library with the spheroids, following the response of individual cells within hundreds of spheroids, and analyzing the results at the single-cell level and as a function of time. The results obtained in this section are noteworthy. First, such detailed data would have been more difficult to obtain using the current state of the art ([@bib22], [@bib36], [@bib53]). Here, the integrated microfluidic format makes the experiments simple to perform and the measurements straightforward. Second, the large number of spheroids involved in the study highlights the presence of a strong heterogeneity of responses near the IC~50~ value, in which some spheroids are viable and others are dead after 24 h. By using the single-cell longitudinal measurements, this variety of responses is found to correlate with the presence of dead cells within the spheroids at the initial moment, indicating that the structural integrity of the spheroid plays a role in its ability to resist a drug treatment.

The viability measurements show complex dynamics, with the emergence of two timescales from the time-resolved single-cell measurements: $\tau_{75}$ that depends on the drug concentration and $\Delta\tau_{75 - 25}$ that does not. These observations suggest that once a spheroid has reached a 75% viability, it will proceed to die at a rate that is proper to the spheroid and independent of the external stimulus. If we consider a particular cell whose neighbors die because of the drug, leading it to lose its focal adhesions and to be subjected to toxic hydrolases, the change in its microenvironment can induce (or at least precipitate) its death for purely structural reasons. Such collective structural effects, which are not present in 2D monolayers, could only be detected by the combination of live imaging and detailed quantitative analysis (intra-spheroid heterogeneity) provided by our technology.

Looking ahead, the technological tools presented here can be transposed to other 3D culture formats, including organoids ([@bib55]), blastoids ([@bib44]), or embryoid bodies ([@bib65]), following some adaptations of the protocols. In addition, it is straightforward to combine the different operations, such as building 3D microenvironments in the microfluidic anchors and then testing the effects of different molecules on these complex models or testing combination treatments involving small molecules, cellular therapy, and other approaches in a single device.

Finally, as stated in the introduction, the most suitable 3D model depends on the question being addressed. So future work will involve a careful choice of the cell types, hydrogels and combinations, the 3D culture format, and validation steps to ensure that the results obtained from the model system are relevant to the *in vivo* conditions. The microfluidic platform described here is designed to make such studies and validation more efficient and reproducible.

STAR★Methods {#sec4}
============

Key Resources Table {#sec4.1}
-------------------

REAGENT or RESOURCESOURCEIDENTIFIER**Antibodies**Alexa Fluor® 647 Mouse Anti-Human CD146 (clone P1H12)BDCat\#563619, RRID: [AB_2738323](nif-antibody:AB_2738323){#interref20}**Biological Samples**Umbilical Cord-Derived Mesenchymal Stem CellsATCCPCS-500-010**Chemicals, Peptides, and Recombinant Proteins**AcetaminophenSigma-AldrichCat\#A7085**Experimental Models: Cell Lines**H4-II-EC3 cellsATCCCRL-1600

Resource Availability {#sec4.2}
---------------------

### Lead Contact {#sec4.2.1}

Further information and requests for resources should be directed to and will be fulfilled by the Lead Contact, Charles N. Baroud (<charles.baroud@pasteur.fr>).

### Materials Availability {#sec4.2.2}

This study did not generate new unique reagents.

### Data and Code Availability {#sec4.2.3}

The code supporting the current study has not been deposited in a public repository but is available from the corresponding author on request.

Experimental Model and Subject Details {#sec4.3}
--------------------------------------

### Cell Culture {#sec4.3.1}

A rat H4-II-EC3 hepatoma cell line (American Type Culture Collection, CRL-1600™, LGC), A-673, an muscle Ewing's Sarcoma cell line (ATCC, CRL-1598™, LGC) and B16-F0, a mouse melanoma cell line (ATCC, CRL-6322™, LGC) were maintained on T-25 cm^2^ flasks (Corning) in a standard CO~2~ incubator (5% (v/v) CO~2~, C150 incubator, Binder), following the instructions provided by the manufacturer. For the H4-II-EC3 and A-673, the culture medium was composed of Dulbecco's Modified Eagle's Medium (DMEM, ThermoFischer) containing high glucose supplemented with 10% (v/v) fetal bovine serum (FBS, ThermoFischer) and 1% (v/v) penicilin-streptamicine (ThermoFischer). For the B16-F0, the culture medium was composed of RPMI 1640 (ThermoFischer), with a similar amount of FBS and antibiotics. The cells were seeded at 5.10^4^ cells/cm^2^ and sub-cultivated every 3 days.

Human mesenchymal stromal cells derived from the Wharton's jelly of umbilical cord (UC-hMSCs) (ATCC, PCS-500-010, lot \#63516504, LGC) were obtained at passage 2. UC-hMSCs were maintained in T-175 cm^2^ flasks (Corning) and cultivated in a CO~2~ incubator. The culture medium was composed of Alpha Modified Eagle's medium (α-MEM) (GIBCO, ThermoFischer) supplemented with 10% (v/v) fetal bovine serum (GIBCO) and 1% (v/v) penicilin-streptamicine (GIBCO). The cells were seeded at 5.10^3^ cells/cm^2^, sub-cultivated every week, and the medium was refreshed every 2 days. UC-hMSCs at passage 2 were first expanded until passage 4 (for about 5-6 populations doublings, PDs), then cryopreserved in 90% (v/v) FBS / 10% (v/v) DMSO and stored in a liquid nitrogen tank. The experiments were carried out with UC-hMSCs at passage 4 to 8 (about 24-35 PDs, after passage 2).

### Bacteria culture {#sec4.3.2}

*Esherichia coli* (K12 - MG 1655-GFP strain) expressing constitutively GFP were cultivated as colonies on LB-agar plates. The day of the fusion experiments, *E.coli* were cultivated in suspension using LB medium up to reaching an O.D. of 0.5.

Method Details {#sec4.4}
--------------

### Estimation of the trapping and drag forces {#sec4.4.1}

Let us consider the anchors described in the main text in [Figures 1](#fig1){ref-type="fig"} and [2](#fig2){ref-type="fig"}. The microfluidic channel has a height h and the circular parts of these anchors have a diameter d and a depth $\text{Δ}h$. In order to estimate the trapping force of the first droplets in the circular parts of the anchors, the variation of surface area before and after trapping must be estimated. The surface area of a confined droplet is estimated by considering pancake shape, meaning a cylinder of radius $R_{i}$, height h surrounded by the outer half of a torus of small radius $\left( {\text{h}/2} \right)$. As we consider the case where the droplet size matches the circular part volume of the asymmetric anchor, the surface area of the trapped droplet is estimated by calculating the area of a cylinder whose section is the circular part of the anchor and whose height is $h + \text{Δ}h$. Thus, the trapping force of the first droplets in the circular parts of the anchors is:$$\mathcal{F}_{trap}^{circ} \sim \text{γ}\frac{\left| {\text{Δ}\mathcal{A}} \right|}{l} \sim 2\text{πγ}\left\lbrack {\frac{2}{d}\left( {1 + \ \frac{h}{4R_{i}} + \frac{h²}{6\text{π}R_{i}^{2}}} \right) - \left( {\frac{d}{2} + \text{h} + \text{Δh}} \right)} \right\rbrack\ $$where the characteristic length l over which the surface energy changes is estimated by $\left( {d/2} \right)$.

For estimating the trapping force of the first droplets in the triangular parts, the triangular parts are assimilated to small circular anchors, whose radius $\left( {d_{eq}/2} \right)$ is smaller than the channel height. According to [@bib13], the resulting trapping force is:$$\mathcal{F}_{trap}^{tri} \sim \gamma\frac{\left| {\text{Δ}\mathcal{A}} \right|}{l} \sim \text{~γ}\frac{\pi}{2}\text{h}\left( {\frac{d_{eq}}{2h} - \frac{4h}{3d_{eq}}\left\lbrack {1 - \left( {1 - \frac{d_{eq}^{2}}{4h^{2}}} \right)^{\frac{3}{2}}} \right\rbrack} \right)$$With the experimental parameters used for [Figure 2](#fig2){ref-type="fig"} ($R_{i}$ = 125 μm, $d$ = 250 μm, $h$ = 95 μm, $\text{Δ}h$ = 50 μm) and assuming $d_{eq}$ = 150 μm (equal to the length and width of the anchor triangle), we have:$$\frac{\mathcal{F}_{trap}^{circ}}{\mathcal{F}_{trap}^{tri}} > \ 100$$So, for the first droplets, the trapping in the circular parts of the anchors is much more efficient than the trapping in the triangular parts.

Also, the drag force exerted by the fluid on a confined droplet scales as $\mathcal{F}_{drag} \sim \text{μ}_{\text{o}}\text{U}\left( {\text{R}^{2}/\text{h}} \right)$, where $U$ and $\mu_{o}$ are respectively the mean velocity and viscosity of the outer fluid. Therefore, the ratio between the drag force exerted on the large first ($R_{1}$ = 170 μm) and small second ($R_{2}\ $ = 80 μm) confined droplets before trapping is:$$\frac{\mathcal{F}_{drag\ 1}}{\mathcal{F}_{drag\ 2}} \sim \ \frac{R_{1}^{2}}{R_{2}^{2}}\  \sim \ 5$$Consequently, if the small droplets experience a similar trapping force in the triangular parts of the anchors than the large droplets, they are exposed to a smaller drag at constant flow rate, meaning that their trapping in the triangular parts of the anchors is more robust.

### Droplet library statistics {#sec4.4.2}

Since secondary droplets get injected and trapped randomly in the anchor array, the number of different barcodes in a chemical library and the number of traps used in the experiment need to be careful chosen. The probability to have one particular barcode in one anchor after droplet merging is $p\  = \ \left( {1/n} \right)$, n being the number of different barcodes. Assuming a completely random trapping of the library droplets in the array, if X is the number of times that a particular barcode is found in an anchor array, the probability P of having exactly i times this particular barcode follows a binomial distribution:$$P\left( {X = i} \right) = \begin{pmatrix}
N_{traps} \\
i \\
\end{pmatrix}p^{i}\left( {1 - p} \right)^{N_{traps} - i}$$As a consequence, the probability of finding at least m times one particular barcode in the array is:$$P\left( {X \geq m} \right) = \ \sum\limits_{i = m}^{N_{traps}}\begin{pmatrix}
N_{traps} \\
i \\
\end{pmatrix}p^{i}\left( {1 - p} \right)^{N_{traps} - i}$$As there are n different barcodes, the probability to have at least m times each of the n possible barcodes in the array is:$$P_{all,\ X \geq m} = \left( {P\left( {X \geq m} \right)} \right)^{n}$$In [Figures 4](#fig4){ref-type="fig"}C--4E, the probability to get at least 1 time each of the 27 barcodes in 224 traps is 0.99.

### Microfabrication {#sec4.4.3}

Molds were mainly fabricated using standard dry film soft lithography. Up to five layers of dry film photoresist, consisting of 50 and 33 μm Eternal Laminar (respectively E8020 and E8013, Eternal Materials, Taiwan) and 15 μm Alpho NIT215 (Nichigo-Morton) negative films, were successively laminated using an office laminator (PEAK pro PS320) at a temperature of 100°C until the desired channel height, from 50 to 200 μm depending on the different cases, was reached. After each laminating step, the photoresist film was exposed to UV (LightningCure, Hamamatsu) through a photomask of the junction, channels, trapping chamber boundaries or anchors. The masters were revealed after washing in a 1% (w/w) K~2~CO~3~ solution (Sigma-Aldrich). For the 3D anchors fabrication ([Figures 3](#fig3){ref-type="fig"}, [4](#fig4){ref-type="fig"}, and [5](#fig5){ref-type="fig"}), a specific method was developed. In these cases, the top of the chip consisted of the flow-focusing device and chambers and the anchors were located at the bottom of these chips. The anchors mold was designed with RhinoCAM software (MecSoft Corporation) and was fabricated by micro-milling a brass plate (CNCMini-Mill/GX, Minitech Machinery). That was also the case for the droplet library producing chips with an aqueous injector and a slope (see [Figure S1](#mmc1){ref-type="supplementary-material"}). The topography of the molds and masters were measured using an optical profilometer (VeecoWyco NT1100, Veeco). For the fabrication of the top of the chip, poly(dimethylsiloxane) (PDMS, SYLGARD 184, Dow Corning, 1 g of curing agent for 10 g of bulk material) was poured over the master and cured for 2 h at 70°C. For the 3D anchors, the metallic mold was first covered with PDMS. Then, a glass slide was immersed into uncured PDMS, above the anchors. The mold was finally heated on a hot plate at 180°C for 15 minutes before extraction of the glass slides covered by a thin layer of PDMS with the anchor pattern. In all cases, the top and the bottom of chip were sealed after plasma treatment (Harrick).

### Chip Design {#sec4.4.4}

Two main different chip designs were used in this study, depending on the presence of cells. For the experiences involving cells ([Figures 3](#fig3){ref-type="fig"}, [4](#fig4){ref-type="fig"}, and [5](#fig5){ref-type="fig"}), the chip design is shown on [Figure 2](#fig2){ref-type="fig"}A. In this case, there were 252 anchors disposed along an hexagonal pattern in the 2 cm^2^ trapping chamber that has a 165 μm height. For the non-biological experiments ([Figure 2](#fig2){ref-type="fig"}), the design was similar but with different dimensions. Notably, the chamber height is 95 μm. In this case, contrary to the cellular chip, the 50 μm deep anchors were patterned on the top of the chamber.

### Experimental Microfluidic Protocol {#sec4.4.5}

The chips were filled 3 times with Novec Surface Modifer (3M), a fluoropolymer coating agent, for 30 min at 110°C on a hot plate. All experiments were conducted using the FC40 fluorinated oil (3M) implemented with a biocompatible FluoroSurfactant (Ran Biotechnologies) at different concentrations. The solutions were loaded in glass (SGE) or plastic (Terumo) syringes, that were actuated with programmable and computer controlled syringe pumps (neMESYS, Cetoni). The syringes were directly connected to the PDMS chips with PTFE tubing (Adtech). For the merging of droplet pairs, the trapping chambers were perfused with a 20% (v/v) 1H,1H,2H,2H-perfluoro-1-octanol (Sigma-Aldrich) solution dissolved in Novec™-7500 Engineered Fluid (3M) at the flowrate indicated in [Table S1](#mmc1){ref-type="supplementary-material"}. The uncolored and dark droplets seen in [Figure 2](#fig2){ref-type="fig"} are respectively made of pure water and of a 6 mM 2,6-dichlorophenolindophenol (2,6-DCPIP, Sigma-Aldrich) aqueous solution.

### Spheroid Formation on Chip {#sec4.4.6}

The chips were first filled with a 3% (w/w) FluoroSurfactant solution. All air bubbles were discarded. H4-II-EC3 cells were detached from the culture flasks with a 2-3 minutes incubation in TrypLE™ Express enzyme (ThermoFischer), that was then inactivated by addition of warm medium. The resulting cell solution was centrifuged (centrifuge 5702 R, Eppendorf) at 2,400 rpm for 6 minutes while the cell concentration was determined using a haemocytometer (Marienfeld). The supernatant was discarded and the cell pellet was resuspended at a 6.10^6^ cells/mL for direct use, or 8.6.10^6^ cells/mL before addition of agarose, in culture medium supplemented with gentamicin (Sigma-Aldrich) to a final concentration of 50 mg/L. When needed, the agarose stock solution was prepared in parallel. Ultra-low gelling agarose (Type IX-A, Sigma-Aldrich) was dissolved at a 3% (w/w) concentration in warm sterile PBS implemented with gentamicin to a final concentration of 50 mg/L and kept at 37°C. 30 μL of the agarose stock solution and 70 μL of the cell solution were mixed to obtain a final cell concentration of 6.10^6^ cells/mL in a 0.9% (w/w) agarose solution. One glass syringe was loaded with this solution and droplets were produced according to the flowrates displayed in [Table S1](#mmc1){ref-type="supplementary-material"}. Spheroids of hMSCs, A673, PC-3 and H4-II-EC3 were formed in droplets containing DMEM medium, while Jurkat and B16-F0 were loaded on chip in RMPI medium. The cell loading was performed at 37°C in a microscope incubator (Okolab) in which all chips, syringes, connectics and solutions were pre-heated. After the loading, all flowrates were stopped, the tubings were cut and the chips were kept immersed in PBS in the CO~2~ incubator. Cells started sedimenting at the bottom of each droplet when the flowrates were stopped. They reorganized overnight in the liquid agarose droplets into spheroids. For the toxicity experiments ([Figures 4](#fig4){ref-type="fig"} and [5](#fig5){ref-type="fig"}), the gelation allowed to immobilize the spheroids at the bottom of their droplets, facilitating live imaging.

### Spheroid Staining for Co-culture Experiments {#sec4.4.7}

A 10 mM solution of CellTracker™ Red and Green (ThermoFischer) was prepared in sterile DMSO (PAN Biotech). H4-II-EC3 cells were incubated for 30 min in culture medium with 10 μM of CellTracker™ in the culture flask, before PBS washing and exposition to the TrypLE™ express enzyme. Alternatively, Jurkat and hMSCs were stained for Vybrant™ Dil (red) and PC-3 were labeled with Vybrant™ Dio (green), following the manufacturer instructions (ThermoFisher).

### Cell sorting {#sec4.4.8}

hMSCs were harvested by scrapping or trypsinization from T-175 cm^2^ flasks. Then, the cells were incubated in staining buffer (2% (v/v) FBS in PBS), stained with a mouse anti-human CD146-Alexa Fluor®647 (Clone P1-H12, BD Bioscience) for 30 min. hMSCs were then sorted based on their level of expression of CD146 using a FACSAria III (BD Bioscience, San Jose, CA): CD146^bright^ constitured 20% of cell population expressiong the highest levels of CD146, while CD146^dim^ constitute 20% of cell population expressiong the lowest levels of CD146.

### Matrigel Droplets {#sec4.4.9}

Matrigel (Matrigel Matrix Basement Membrane, Corning) was aliquoted and kept at −20°C. One aliquot was thawed on ice for about 30 min before the experiment. Droplets were produced, trapped close to the spheroid droplets and merged at 4°C in a cold room. The chip was then kept in the cell incubator at 37°C allowing the gelation to take place.

### Protocol For Droplet Library Production {#sec4.4.10}

Droplet libraries were produced following two successive steps. First, the two solutions of interest were mixed at a PEEK cross junction (Upchurch) in known ratios controlled by programmable syringe pumps (neMESYS, Cetoni). Between each different ratio, a plug of oil (FC40 with a 0.25% (w/w) concentration of FluoroSurfactant) was injected at the cross junction for physically separating the different droplets in the exit tubing. This technique is called micro-segmented flow ([@bib19]) and results in a train of microliter droplets separated by oil, each of them with a different ratio of the two aqueous stock solutions (see [Figures S2](#mmc1){ref-type="supplementary-material"}A--S2C). In the present study, the ratios followed either a linear ([Figure 2](#fig2){ref-type="fig"}; [Figure S1](#mmc1){ref-type="supplementary-material"}) or logarithmic ([Figures 4](#fig4){ref-type="fig"} and [5](#fig5){ref-type="fig"}) progression.

Second, these segments were partitioned into nanoliter droplets ([@bib30]) using a specific droplet producing chip ([Figure S1](#mmc1){ref-type="supplementary-material"}). The segments were injected in a chamber filled with oil through a slope (see [Figure S1](#mmc1){ref-type="supplementary-material"}A). The slope allows to continuously deconfine the aqueous phase that spontaneously breaks into monodisperse droplets, without the need of an external oil flow ([Figure S1](#mmc1){ref-type="supplementary-material"}B). The droplet size is governed by the geometrical parameters of the injector, namely its height and width, as well as the angle of the slope. The nanoliter droplets resulting from this production were brought in the storage chamber of the chip thanks to a small continuous oil flow (FC40 with 6% (w/w) FluoroSurfactant) at the corner of the slope ([Figures S1](#mmc1){ref-type="supplementary-material"}C and S1D). The droplets ascended to the top of this very deep storage chamber resulting in the trapping of the produced droplet library.

### Droplet Library Injection in the Anchors Array {#sec4.4.11}

During the segment partitioning, the droplets were kept in the storage chamber of the microfluidic droplet producing chip. Before injection into a trapping chamber with capillary anchors, the droplet producing chip was manually flipped over several times to mix the different droplet types inside the storage chamber ([Figure S2](#mmc1){ref-type="supplementary-material"}G). Then, the chip was connected to the aqueous inlet of anchor array chip, and it was maintained upside down to allow the droplets to escape the storage chamber ([Figure S1](#mmc1){ref-type="supplementary-material"}M). Using the aqueous inlet for the droplet injection presented several advantages. The separation between the droplets in the trapping chip was controlled by the oil flowrate at the junction inlet and it also broke down possible large droplets coming from a coalescence event during the droplet transfer. In addition, the flowrate in the chamber was controlled independently with the chamber inlet.

### Food Dye Droplet Library Production {#sec4.4.12}

The color droplets shown in [Figure 2](#fig2){ref-type="fig"} and [Figure S1](#mmc1){ref-type="supplementary-material"} were produced by mixing commercially available yellow, blue, red food dyes (Vahiné) and pure water in known ratios. The syringe pumps were programmed to create 11 segments (5 with a linear increase of the first solution, 1 purely made of the first solution, and 5 with a linear decrease of first solution), each of 2 μL, separated by 1 μL of oil at a global constant flowrate of 20 μL/min. To partition these segments at the desired volumes, two droplet producing chips were used. For the first and second droplets, the geometrical parameters of the chip were respectively a slope of 8 and 11%, an injector width of 100 and 90 μm and an injector height of 40 μm for both. The flowrates are indicated in [Table S1](#mmc1){ref-type="supplementary-material"}.

### Droplet library production with fluo barcodes {#sec4.4.13}

3 fluorescent dyes at 3 concentrations were mixed in a combinatorial manner to obtain 27 barcodes. CF™647 hydrazide was used at 70.0 μM, 18.7 μM and 5.00 μM. CF™488A hydrazide was used at 100 μM, 9.49 μM and 900 nM. CF™405 hydrazide was used at 350 μM, 102 μM and 30.0 μM. These signal of these 3 dyes is respectively represented in [Figures 4](#fig4){ref-type="fig"}C--4E in red, green and blue. Acetaminophen (APAP, Sigma-Aldrich) was added at a 225 mM concentration in the solution corresponding to barcode \#09. All solutions were implemented with DMSO (8% (v/v)), gentamicin (50 mg/L) and propidium iodide (3.0 μM, Sigma-Aldrich).

1 μL of each barcode solution was aspirated sequentially, with 1 μL of fluorinated oil in between each plug. These segments were injected in a droplet production chip with the following geometrical parameters: an injector width and height respectively of 100 and 40 μm and a slope of 8%. The volume of the first (with the cells) and second (with the drug) droplets was respectively estimated to 12 nL and 60 nL, so the dilution factor from the library to the post-merging droplets was approximately 6.

### Acetaminophen Droplet Library Production {#sec4.4.14}

Two stock solutions were prepared for the acetaminophen (APAP, Sigma-Aldrich) droplet library production, with a 3 mM and 300 mM drug concentration. Both of them were implemented with DMSO (8% (v/v)) and gentamicin (50 mg/L). For the live viability staining, the 2 solutions of the manufacturer (ReadyProbes™ Cell Viability Imaging Kit (Blue/Red), ThermoFischer) were diluted to a 17.5% (v/v) concentration. The low and high APAP drug concentration solutions were marked respectively with a green and red fluorescent dye (CF™488A hydrazide and CF™647 hydrazide, Sigma-Aldrich) at a 7 μM concentration. The dilutant was culture medium. These fluorescent dyes did not have any observable effect on the spheroids viability at the highest concentration used in this study. A solution was also prepared for the control droplets with the same composition as the drug solution (including DMSO), without the APAP and the CF™ fluorescent dyes.

12 segments of 3 μL each were produced to cover regularly a logarithmic scale between the low and high concentration solutions. An additional 3 μL segment of the control solution was added before partitioning. These segments were injected in a droplet production chip with the following geometrical parameters: an injector width and height respectively of 100 and 40 μm and a slope of 8%. The volume of the first (with the cells) and second (with the drug) droplets was respectively estimated to 12 nL and 60 nL, so the dilution factor from the library to the post-merging droplets was approximately 6. The concentration range tested here corresponded to a large excess of APAP molecules (about 10^8^ APAP molecules per cell in a 1 mM APAP droplet).

### Determination of the APAP Concentration in Droplets {#sec4.4.15}

The drug concentration in the droplets was determined right after the merging of the spheroid and drug droplets by measuring the signals from the CF™ dyes. For each anchor, the fluorescent signal was defined as the local background (average of the signal just outside this anchor) subtracted from the raw fluorescent intensity (average of the raw intensity in the middle of the deep part of the anchor). This signal was correlated to a drug concentration using the calibration curves of the CF™ dyes shown in [Figure 4](#fig4){ref-type="fig"}C. In order to replicate the conditions of the experiments, the calibration was made by trapping large droplets of culture medium in the deep parts of the anchors with a similar concentration of viability dyes, DMSO and a known concentration of each CF™ dye. 4 concentrations were loaded in each chip at the same time ([@bib47]), giving about 60 fluorescent droplets per concentration. 2 chips were used for getting the 8 measurements of each calibration curve. The droplets were imaged with the same experimental parameters than for the toxicity experiments.

### Diffusion of PI in the Spheroids {#sec4.4.16}

Spheroids were formed with H4-II-EC3 at 6.10^6^ cells/mL in droplets containing 0.9% (w/w) agarose, as described in the section "Spheroid Formation on Chip." After spheroid formation, the agarose was gelled by placing the chip at 4°C for 20 min. The oil phase was then exchanged to culture medium containing 50 mM APAP. The chip was then incubated for 24h. The day of the experiment, a solution of 1 mL of culture medium containing two drops of ReadyProbes Red (PI, ThermoFischer) was perfused in the culture culture chamber and image acquisition was started at the same time.

### Image Acquisition {#sec4.4.17}

Images without cells were acquired either on a binocular (MZ16 FA, Leica) using a CCD camera (Insight camera, 4MP Firewire, SPOT), or, for the colored droplets, with a digital single-lens reflex camera (D7000, Nikon). The droplet production images of [Figure S1](#mmc1){ref-type="supplementary-material"}B were acquired with a high speed camera (FASTCAM 1024 PCI, Photron). The cellular fluorescent images were taken with an inverted microscope (Eclispe Ti, Nikon), equipped of a motorized stage, an illumination system (Spectra-X, Lumencor) and a temperature controlled incubator (Okolab), with a CMOS camera (ORCA Flash 4.0, Hamamatsu).

Quantification and Statistical Analysis {#sec4.5}
---------------------------------------

### Image Analysis {#sec4.5.1}

For quantifying the droplet colors in [Figure 2](#fig2){ref-type="fig"}, the entire array was imaged using the binocular and the reflex camera. Then, a custom MATLAB code (R2016a, Mathworks) allowed to detect each anchor and to compute the RGB values in the center of each droplet, before and after merging. For the droplet fluorescent barcode assignment in [Figure 4](#fig4){ref-type="fig"} and [Figure S5](#mmc1){ref-type="supplementary-material"}, a signal range was manually set for each dye concentration, leaving the few droplets having one signal out of range unassigned.

For the toxicity experiment, single images of the anchors were acquired automatically with the motorized stage of the microscope. The analysis was conducted on a montage of the detected anchors using a protocol previously described ([@bib47]). Briefly, cells were detected using bright field and fluorescent intensities, and spheroids were selected based on morphological parameters. For each spheroid, the local background was used to determine a specific threshold for the fluorescent dead cells. The viability at the spheroid level was then defined as:$$viability\left( \% \right) = \ 1\  - \ \frac{N_{dead\ pixels}}{A}$$$N_{dead\ pixels}$ and $A$ being respectively the number of dead pixels and area of the spheroid. A similar analysis was conducted for determining the viability of the 2D cultures.

At the cellular level, dead cell centers were detected as the local maxima of the fluorescent mortality marker, above the local threshold. Then, the radial distance of each dead cell center was computed and compared to the equivalent radius R of the spheroid to define the mean normalized distance of dead cell centers to the spheroid center $\left( {r/R} \right)_{dead}$. It was close to 0 if all detected dead cells were close to the spheroid center and close to 1 if they were close to the spheroid edge.

### Statistical analysis {#sec4.5.2}

^∗^p \< 0.05; ^∗∗^p \< 0.01; ^∗∗∗^p \< 0.001; N.S.: non-significant. p value ranges are only indicated for the highlighted comparisons. For each test, the normality and equality of variances (homoscedasticity) were tested using respectively Anderson-Darling and Bartlett's tests. Then, the proper statistical test was chosen accordingly each case. Details of the hypothesis and p values can be found in [Table S2](#mmc1){ref-type="supplementary-material"}. In the Tukey box-and-whiskers figures ([Figure 6](#fig6){ref-type="fig"}), the boxes represent the first (q1) and third (q3) quartiles with the median shown by the line bissecting the box, and the mean is shown with black circles. The whiskers represent 1.5 times the inter-quartile range (q3-q1) of the sample. Finally, the box width is proportional to $\sqrt{n}$. Exact values of n are reported in each figure legend.
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